Form D — Iambic Therapeutics, Inc.
0001997038-26-000001 · filed Apr 8, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $49,999,996
- Reported amount sold
- $27,769,668
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Iambic Therapeutics, Inc.
- CIK
- 1997038
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO, California 92121 - Phone
- (619) 330-5499
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Miller · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Fred Manby · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Neil Josephson · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Michael Secora · Executive OfficerSan Diego, California Find on LinkedIn ↗
-
Jishnu Bhattacharjee · DirectorSan Diego, California Find on LinkedIn ↗
-
Evan Rachlin · DirectorSan Diego, California Find on LinkedIn ↗
-
R. Jacob Vogelstein · DirectorSan Diego, California Find on LinkedIn ↗
-
Mary Tagliaferri · DirectorSan Diego, California Find on LinkedIn ↗
-
William Rastetter · DirectorSan Diego, California Find on LinkedIn ↗
-
Kurt von Emster · DirectorSan Diego, California Find on LinkedIn ↗
-
Shalini Sharp · DirectorSan Diego, California Find on LinkedIn ↗
-
Pete Olson · Executive OfficerSan Diego, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗